Abstract:Abstract In the hypothetical RNA world, ribozymes could have acted as modern aminoacyl-tRNA synthetases (ARSs) to charge tRNAs, thus giving rise to the peptide synthesis along with the evolution of a primitive translation apparatus. We previously reported a T-boxzyme, Tx2.1, which selectively charges initiator tRNA with N-biotinyl-phenylalanine (BioPhe) in situ in a Flexible In-vitro Translation (FIT) system to produce BioPhe-initiating peptides. Here, we performed in vitro selection of elongation-capable T-boxzymes (elT-boxzymes), using para-azido-l-phenylalanine (PheAZ) as an acyl-donor. We implemented a new strategy to enrich elT-boxzyme-tRNA conjugates that self-aminoacylated on the 3′-terminus selectively. One of them, elT32, can charge PheAZ onto tRNA in trans in response to its cognate anticodon. Further evolution of elT32 resulted in elT49, with enhanced aminoacylation activity. We have demonstrated the translation of a PheAZ-containing peptide in an elT-boxzyme-integrated FIT system, revealing that elT-boxzymes are able to generate the PheAZ-tRNA in response to the cognate anticodon in situ of a custom-made translation system. This study, together with Tx2.1, illustrates a scenario where a series of ribozymes could have overseen aminoacylation and co-evolved with a primitive RNA-based translation system.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to generate elongator nonproteinogenic aminoacyl - tRNA capable of recognizing specific anticodons in a custom - made translation system. Specifically, the researchers hope to develop new tRNA - sensing aminoacylating ribozymes (T - boxzymes) so that they can generate tRNAs with specific amino acids at specific sites according to specific anticodons in an in vitro translation system, thereby achieving peptide chain synthesis of unnatural amino acids. ### Background and Objectives In the hypothesized RNA world, ribozymes may have played the role of modern amino acid - tRNA synthetases (ARSs), being responsible for loading amino acids onto tRNAs, thereby promoting peptide chain synthesis and accompanying the evolution of the original translation apparatus. Previously, the research team has reported a T - boxzyme named Tx2.1, which can selectively load N - biotin - phenylalanine (BioPhe) onto the initiator tRNA in a custom - made translation system, producing peptide chains starting with BioPhe. However, Tx2.1 is only applicable to the expression of peptide chains with biotin at the N - terminus. To overcome this limitation, this study aims to develop new tRNA - sensing aminoacylating ribozymes that can use N - terminus - free substrates, namely para - azido - L - phenylalanine (Phe AZ), and perform aminoacylation at the 3' end of tRNAs in response to specific anticodons. Through this method, the researchers hope to further expand the application range of unnatural amino acids in peptide chains, especially in custom - made translation systems. ### Methods and Results 1. **In vitro screening method**: The researchers used a click - reaction - based method to screen for new T - boxzymes. By using Phe AZ - CME as an aminoacylation substrate, ribozymes capable of performing aminoacylation at the 3' end of tRNAs were screened out. 2. **Self - aminoacylation and characterization**: After multiple rounds of in vitro screening, the researchers discovered some ribozymes capable of self - aminoacylation. These ribozymes mainly perform aminoacylation at the internal 2' - hydroxy position rather than at the 3' end. These ribozymes were named inT - boxzymes. 3. **Optimization and verification**: Through further optimization of the screened inT - boxzymes, the researchers obtained a ribozyme named elT32, which can selectively perform aminoacylation at the 3' end of tRNAs and has a high selectivity for specific anticodons. After further optimization, a more active elT49 was obtained. 4. **Application in translation systems**: Finally, the researchers verified the functions of elT - boxzymes in a custom - made translation system (FIT system) and successfully synthesized peptide chains containing Phe AZ. ### Conclusions This study not only shows how to develop new tRNA - sensing aminoacylating ribozymes through in vitro screening methods but also proves that these ribozymes can generate specific unnatural amino acid - tRNAs in custom - made translation systems, thereby achieving peptide chain synthesis. This provides a new perspective for future research on ribozyme functions in the RNA world hypothesis and also paves a new way for the application of unnatural amino acids in protein engineering.

An anticodon-sensing T-boxzyme generates the elongator nonproteinogenic aminoacyl-tRNA in situ of a custom-made translation system for incorporation

Chimeric design of pyrrolysyl-tRNA synthetase/tRNA pairs and canonical synthetase/tRNA pairs for genetic code expansion

Engineering a ribozyme with aminoacyl-tRNA synthetase activity

Structure-guided aminoacylation and assembly of chimeric RNAs

A potential role for RNA aminoacylation prior to its role in peptide synthesis

Biocatalytic polymer synthesis with β-amino acids

Fine-tuning the tRNA anticodon arm for multiple/consecutive incorporations of β-amino acids and analogs

Directed-evolution of Translation System for Efficient Unnatural Amino Acids Incorporation and Generalizable Synthetic Auxotroph Construction.

Expanding the Scope of Ribosome‐Mediated Biosynthesis in vitro using tRNA‐Aminoacylating Ribozyme

Triplet-Encoded Prebiotic RNA Aminoacylation

Translating protein enzymes without aminoacyl-tRNA synthetases

Elongation factor-Tu can repetitively engage aminoacyl-tRNA within the ribosome during the proofreading stage of tRNA selection

Potentially prebiotic synthesis of aminoacyl-RNA via a bridging phosphoramidate-ester intermediate

Primordial aminoacyl-tRNA synthetases preferred minihelices to full-length tRNA

Translation initiation with exotic amino acids using EF-P-responsive artificial initiator tRNA

A Designed, Highly Efficient Pyrrolysyl-tRNA Synthetase Mutant Binds O-Chlorophenylalanine Using Two Halogen Bonds

Nonenzymatic assembly of active chimeric ribozymes from aminoacylated RNA oligonucleotides

Development of orthogonal aminoacyl-tRNA synthetase mutant for incorporating a non-canonical amino acid

Ribosomal Peptide Syntheses from Activated Substrates Reveal Rate Limitation by an Unexpected Step at the Peptidyl Site

RNA-directed peptide synthesis across a nicked loop

Engineering tRNAs for the Ribosomal Translation of Non-proteinogenic Monomers